India’s identity as the Pharmacy of the World was built on affordable generic medicines that transformed access to healthcare worldwide. Today, the government’s Biopharma SHAKTI initiative signals the start of the industry’s next chapter. Achieving that ambition will require far more than scientific breakthroughs and manufacturing excellence.

It will depend on intelligent, resilient and globally connected supply chains that can deliver the next generation of therapies safely, reliably and at scale. What it will take for the pharmaceutical, biopharma, medical device and logistics industries to work together to build the digitally connected, resilient ecosystem needed to turn that ambition into reality.